Variable influence of statins on isoprostanes in hyperlipidemia

Advances in Experimental Medicine and Biology

Volumn 525, Issue , 2003, Pages 209-212

  Sinzinger, Helmut ^b   Oguogho, Anthony ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPROSTANE; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; CIGARETTE SMOKING; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN URINE LEVEL;

EID: 0038205467     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9194-2_45     Document Type: Conference Paper

References (3)

1. Sinzinger H, Wolfram RM, Peskar BA. Muscular side effects of statins. J. Cardiovasc. Pharmacol. 2002; 40: 163-171.
2. 2α, in statin-induced myopathy. in: Proc Advances in Prostaglandin and Leukotriene Research. B Samuelsson, R Paoletti, PC Folco, E Granström (Eds) Kluwer Academic Publ, Dordrecht, 2001, pp. 197-199.
3. Phillips PS, Hass R H, Bannykh S, Hathaway S, Gray NL, Kimura BJ, England J.D.F. Scripps Mercy Clinical Research Center. Statin associated myopathy with normal and abnormal creatine kinase: clinical, pathologic and biochemical features. Ann Intern Med, 2002; 137: 581-585